Benitec Biopharma Inc. Common Stock

BNTCNASDAQ • USD
ThemeGenomics & Precision Med.›Gene Therapy & Gene Editing
8.59 USD
↘ 0.06 (0.69%)AT CLOSE (03:59 PM EDT)
8.60
↗ 0.01 (0.06%)
POST MARKET (AS OF 04:04 PM EDT)
Post Market
AS OF 04:04 PM EDT
8.60
↗ 0.01 (0.06%)
🔴Market: CLOSED

BNTC is currently priced at $8.59. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest BNTC is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Oct 26, 2026.

Open?$8.71
High?$8.80
Low?$8.54
Prev. Close?$8.65
Volume?98.6K
Avg. Volume?199.2K
VWAP?$8.63
Rel. Volume?0.50x
Bid / Ask
Bid?$7.35 × 100
Ask?$10.80 × 100
Spread?$3.45
Midpoint?$9.08
Valuation & Ratios
Market Cap?301.8M
Shares Out?34.9M
Float?21.1M
Float %?61.4%
P/E Ratio?N/A
P/B Ratio?1.70
EPS?-$1.31
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.
Themes
Healthcare - Genomics & Precision Medicine›Gene Therapy & Gene EditingBiotech - Drug Development›Rare Disease Therapeutics
Employees
24
Market Cap
301.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.benitec.com
Listed
2012-07-11
Address
3940 TRUST WAY
HAYWARD, CA 94545
Phone: (510) 780-0819
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
48
Piotroski F-Score?0/9Weak
Altman Z-Score?30.41Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?9.44%Elevated
Short Interest?2.0M
Days to Cover?10.1
Free Float21.1M
Avg Daily Volume197.8K
Settlement Date2026-10-15
Financial Health
Current Ratio?34.00Strong
Quick Ratio?34.00Strong
Cash Ratio?33.68Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
82
1.70CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
7
-25.7%WEAK▾
ROA?
S&P
3
-24.9%WEAK▾
Cash Flow & Enterprise
FCF?$-16623000
Enterprise Value?$121.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist